# Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours

> **NCT04907422** · — · COMPLETED · sponsor: **Amina Fouad Farag** · enrollment: 60 (actual)

## Conditions studied

- Carcinoma Ex Pleomorphic Adenoma of Salivary Glands
- Pleomorphic Adenoma of Salivary Glands

## Interventions

- **DIAGNOSTIC_TEST:** CD24-Gold Nanocomposite expression using Real-time quantitative polymerase chain reaction
- **DIAGNOSTIC_TEST:** non-conjugated CD24 expression using Real-time quantitative polymerase chain reaction

## Key facts

- **NCT ID:** NCT04907422
- **Lead sponsor:** Amina Fouad Farag
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2019-02-03
- **Final completion:** 2021-02-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907422, "Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04907422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*